{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T19:28:02Z","timestamp":1784057282972,"version":"3.55.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,3,30]],"date-time":"2017-03-30T00:00:00Z","timestamp":1490832000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s00347-017-0483-1","type":"journal-article","created":{"date-parts":[[2017,3,30]],"date-time":"2017-03-30T06:30:20Z","timestamp":1490855420000},"page":"504-513","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Pathophysiologie der atopischen Blepharokeratokonjunktivitis","Pathophysiology of atopic blepharokeratoconjunctivitis"],"prefix":"10.1007","volume":"114","author":[{"given":"T.","family":"Lapp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Jakob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Reinhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,30]]},"reference":[{"key":"483_CR1","unstructured":"Altmeyer P Ekzem atopisches (\u00dcbersicht) (2017). In: Enzyklop\u00e4die der Dermatologie, Venerologie, Allergologie, Umweltmedizin. \n                        http:\/\/www.enzyklopaedie-dermatologie.de\/artikel?id=1108\n                        \n                    . Zugegriffen: 15. Nov. 2016"},{"key":"483_CR2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2332\/allergolint.13-RAI-0564","volume":"62","author":"DYM Leung","year":"2013","unstructured":"Leung DYM (2013) New insights into atopic dermatitis: role of skin barrier and immune dysregulation. Allergol Int 62:151\u2013161","journal-title":"Allergol Int"},{"key":"483_CR3","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1038\/jid.2009.133","volume":"129","author":"MJ Cork","year":"2009","unstructured":"Cork MJ et\u00a0al (2009) Epidermal barrier dysfunction in atopic dermatitis. J\u00a0Invest Dermatol 129:1892\u20131908","journal-title":"J Invest Dermatol"},{"key":"483_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/path.4810","author":"SJ Brown","year":"2016","unstructured":"Brown SJ (2016) Molecular mechanisms in atopic eczema: insight gained from genetic studies. J\u00a0Pathol. doi:\n                        10.1002\/path.4810","journal-title":"J Pathol"},{"key":"483_CR5","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jaci.2016.06.010","volume":"138","author":"T Werfel","year":"2016","unstructured":"Werfel T et\u00a0al (2016) Cellular and molecular immunologic mechanisms in patients with atopic dermatitis. J\u00a0Allergy Clin Immunol 138:336\u2013349","journal-title":"J Allergy Clin Immunol"},{"key":"483_CR6","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jaci.2012.12.668","volume":"131","author":"MA McAleer","year":"2013","unstructured":"McAleer MA, Irvine AD (2013) The multifunctional role of filaggrin in allergic skin disease. J\u00a0Allergy Clin Immunol 131:280\u2013291","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"483_CR7","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jaci.2008.02.039","volume":"121","author":"WHI McLean","year":"2008","unstructured":"McLean WHI et\u00a0al (2008) Filaggrin variants confer susceptibility to asthma. J\u00a0Allergy Clin Immunol 121(5):1294\u20131295","journal-title":"J Allergy Clin Immunol"},{"key":"483_CR8","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1600-065X.2011.01027.x","volume":"242","author":"M Boguniewicz","year":"2011","unstructured":"Boguniewicz M, Leung DYM (2011) Atopic dermatitis: a\u00a0disease of altered skin barrier and immune dysregulation. Immunol Rev 242:233\u2013246","journal-title":"Immunol Rev"},{"key":"483_CR9","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/j.1398-9995.2012.02845.x","volume":"67","author":"T Bieber","year":"2012","unstructured":"Bieber T (2012) Atopic dermatitis 2.0: from the clinical phenotype to the molecular taxonomy and stratified medicine. Allergy 67:1475\u20131482","journal-title":"Allergy"},{"key":"483_CR10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s40257-013-0033-9","volume":"14","author":"KL Hon","year":"2013","unstructured":"Hon KL, Leung AKC, Barankin B (2013) Barrier repair therapy in atopic dermatitis: an overview. Am J Clin Dermatol 14:389\u2013399","journal-title":"Am J Clin Dermatol"},{"key":"483_CR11","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1610-0387.2005.05068.x","volume":"3","author":"E Proksch","year":"2005","unstructured":"Proksch E, Lachapelle J\u2011M (2005) The management of dry skin with topical emollients \u2013 recent perspectives. J\u00a0Dtsch Dermatol Ges 3:768\u2013774","journal-title":"J Dtsch Dermatol Ges"},{"key":"483_CR12","doi-asserted-by":"crossref","first-page":"218","DOI":"10.5124\/jkma.2014.57.3.218","volume":"57","author":"EH Choi","year":"2014","unstructured":"Choi EH, Yoon NY (2014) Pathogenesis of atopic dermatitis. J\u00a0Korean Med Assoc 57:218\u2013225","journal-title":"J Korean Med Assoc"},{"key":"483_CR13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/all.12784","volume":"71","author":"SA Alduraywish","year":"2016","unstructured":"Alduraywish SA et al (2016) The march from early life food sensitization to allergic disease: a\u00a0systematic review and meta-analyses of birth cohort studies. Allergy 71:77\u201389","journal-title":"Allergy"},{"key":"483_CR14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/all.12246","volume":"69","author":"S Deckert","year":"2014","unstructured":"Deckert S, Kopkow C, Schmitt J (2014) Nonallergic comorbidities of atopic eczema: an overview of systematic reviews. Allergy 69:37\u201345","journal-title":"Allergy"},{"key":"483_CR15","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/all.12184","volume":"68","author":"K Eyerich","year":"2013","unstructured":"Eyerich K, Novak N (2013) Immunology of atopic eczema: overcoming the Th1\/Th2 paradigm. Allergy 68:974\u2013982","journal-title":"Allergy"},{"key":"483_CR16","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/ACI.0000000000000198","volume":"15","author":"J Thijs","year":"2015","unstructured":"Thijs J et al (2015) Biomarkers for atopic dermatitis: a\u00a0systematic review and meta-analysis. Curr Opin Allergy Clin Immunol 15:453\u2013460","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"483_CR17","doi-asserted-by":"crossref","first-page":"858","DOI":"10.3390\/jcm4050858","volume":"4","author":"Y Mansouri","year":"2015","unstructured":"Mansouri Y, Guttman-Yassky E (2015) Immune pathways in atopic dermatitis, and definition of biomarkers through broad and targeted therapeutics. J\u00a0Clin Med 4:858\u2013873","journal-title":"J Clin Med"},{"key":"483_CR18","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jaci.2012.02.020","volume":"129","author":"A Rebane","year":"2012","unstructured":"Rebane A et al (2012) Mechanisms of IFN-\u03b3-induced apoptosis of human skin keratinocytes in patients with atopic dermatitis. J\u00a0Allergy Clin Immunol 129:1297\u20131306","journal-title":"J Allergy Clin Immunol"},{"key":"483_CR19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI9199","volume":"106","author":"A Trautmann","year":"2000","unstructured":"Trautmann A et al (2000) T cell-mediated Fas-induced keratinocyte apoptosis plays a\u00a0key pathogenetic role in eczematous dermatitis. J\u00a0Clin Invest 106:25\u201335","journal-title":"J Clin Invest"},{"key":"483_CR20","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/1523-1747.ep12331164","volume":"107","author":"T Werfel","year":"1996","unstructured":"Werfel T et al (1996) Allergen specificity of skin-infiltrating T cells is not restricted to a\u00a0type-2 cytokine pattern in chronic skin lesions of atopic dermatitis. J\u00a0Invest Dermatol 107:871\u2013876","journal-title":"J Invest Dermatol"},{"key":"483_CR21","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S0091-6749(96)80161-8","volume":"97","author":"T Thepen","year":"1996","unstructured":"Thepen T et\u00a0al (1996) Biphasic response against aeroallergen in atopic dermatitis showing a\u00a0switch from an initial TH2 response to a\u00a0TH1 response in situ: an immunocytochemical study. J\u00a0Allergy Clin Immunol 97:828\u2013837","journal-title":"J Allergy Clin Immunol"},{"key":"483_CR22","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1056\/NEJMoa021481","volume":"347","author":"PY Ong","year":"2002","unstructured":"Ong PY et\u00a0al (2002) Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N\u00a0Engl J Med 347:1151\u20131160","journal-title":"N Engl J Med"},{"key":"483_CR23","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.immuni.2006.02.006","volume":"24","author":"MD Howell","year":"2006","unstructured":"Howell MD et\u00a0al (2006) Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity 24:341\u2013348","journal-title":"Immunity"},{"key":"483_CR24","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/jid.2013.291","volume":"134","author":"T Volz","year":"2014","unstructured":"Volz T et al (2014) Nonpathogenic bacteria alleviating atopic dermatitis inflammation induce IL-10-producing dendritic cells and regulatory Tr1 cells. J\u00a0Invest Dermatol 134:96\u2013104","journal-title":"J Invest Dermatol"},{"key":"483_CR25","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jaci.2014.02.017","volume":"134","author":"S Kaesler","year":"2014","unstructured":"Kaesler S et al (2014) Toll-like receptor 2 ligands promote chronic atopic dermatitis through IL-4-mediated suppression of IL-10. J\u00a0Allergy Clin Immunol 134:92\u201399","journal-title":"J Allergy Clin Immunol"},{"key":"483_CR26","doi-asserted-by":"publisher","DOI":"10.3410\/f.726815273.793527741","author":"EL Simpson","year":"2017","unstructured":"Simpson EL et\u00a0al (2017) Two phase 3 trials of dupilumab versus placebo in atopic dermatitis. N\u00a0Engl J Med. doi:\n                        10.3410\/f.726815273.793527741","journal-title":"N Engl J Med"},{"key":"483_CR27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(15)00388-8","volume":"387","author":"D Tha\u00e7i","year":"2016","unstructured":"Tha\u00e7i D et al (2016) Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a\u00a0randomised, placebo-controlled, dose-ranging phase 2b trial. Lancet Lond Engl 387:40\u201352","journal-title":"Lancet Lond Engl"},{"key":"483_CR28","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1398-9995.2005.00791.x","volume":"60","author":"JM Oldhoff","year":"2005","unstructured":"Oldhoff JM et al (2005) Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis. Allergy 60:693\u2013696","journal-title":"Allergy"},{"key":"483_CR29","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jaci.2007.11.016","volume":"121","author":"D Simon","year":"2008","unstructured":"Simon D, H\u00f6sli S, Kostylina G, Yawalkar N, Simon H\u2011U (2008) Anti-CD20 (rituximab) treatment improves atopic eczema. J\u00a0Allergy Clin Immunol 121:122\u2013128","journal-title":"J Allergy Clin Immunol"},{"key":"483_CR30","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.jaci.2011.09.009","volume":"128","author":"AA Navarini","year":"2011","unstructured":"Navarini AA, French LE, Hofbauer GFL (2011) Interrupting IL-6-receptor signaling improves atopic dermatitis but associates with bacterial superinfection. J\u00a0Allergy Clin Immunol 128:1128\u20131130","journal-title":"J Allergy Clin Immunol"},{"key":"483_CR31","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jaad.2005.03.013","volume":"53","author":"RL Buka","year":"2005","unstructured":"Buka RL, Resh B, Roberts B, Cunningham BB, Friedlander S (2005) Etanercept is minimally effective in 2 children with atopic dermatitis. J\u00a0Am Acad Dermatol 53:358\u2013359","journal-title":"J Am Acad Dermatol"},{"key":"483_CR32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0190-9622(93)70026-P","volume":"28","author":"JM Hanifin","year":"1993","unstructured":"Hanifin JM et\u00a0al (1993) Recombinant interferon gamma therapy for atopic dermatitis. J\u00a0Am Acad Dermatol 28:189\u2013197","journal-title":"J Am Acad Dermatol"},{"key":"483_CR33","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.12958","author":"J Schmitt","year":"2016","unstructured":"Schmitt J et al (2016) Einsatz und Wirksamkeit von Systemtherapien bei Erwachsenen mit schwerer Neurodermitis: Erste Ergebnisse des deutschen Neurodermitis-Registers TREATgermany. J\u00a0Dtsch Dermatol Ges. doi:\n                        10.1111\/ddg.12958","journal-title":"J Dtsch Dermatol Ges"},{"key":"483_CR34","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jaci.2014.05.022","volume":"134","author":"A Rebane","year":"2014","unstructured":"Rebane A et al (2014) MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes. J\u00a0Allergy Clin Immunol 134:836\u2013847.e11","journal-title":"J Allergy Clin Immunol"},{"key":"483_CR35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jaci.2013.04.011","volume":"132","author":"A Rebane","year":"2013","unstructured":"Rebane A, Akdis CA (2013) MicroRNAs: essential players in the regulation of inflammation. J\u00a0Allergy Clin Immunol 132:15\u201326","journal-title":"J Allergy Clin Immunol"},{"key":"483_CR36","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMra1011040","volume":"365","author":"AD Irvine","year":"2011","unstructured":"Irvine AD, McLean WHI, Leung DYM (2011) Filaggrin mutations associated with skin and allergic diseases. N\u00a0Engl J Med 365:1315\u20131327","journal-title":"N Engl J Med"},{"key":"483_CR37","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1242\/jcs.033969","volume":"122","author":"A Sandilands","year":"2009","unstructured":"Sandilands A, Sutherland C, Irvine AD, McLean WHI (2009) Filaggrin in the frontline: role in skin barrier function and disease. J\u00a0Cell Sci 122:1285\u20131294","journal-title":"J Cell Sci"},{"key":"483_CR38","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1600-0625.2008.00786.x","volume":"17","author":"E Proksch","year":"2008","unstructured":"Proksch E, Brandner JM, Jensen J\u2011M (2008) The skin: an indispensable barrier. Exp Dermatol 17:1063\u20131072","journal-title":"Exp Dermatol"},{"key":"483_CR39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00424-016-1903-9","volume":"469","author":"K B\u00e4sler","year":"2017","unstructured":"B\u00e4sler K, Brandner JM (2017) Tight junctions in skin inflammation. Pfl\u00fcgers Arch 469:3\u201314","journal-title":"Pfl\u00fcgers Arch"},{"key":"483_CR40","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0955-0674(02)00362-9","volume":"14","author":"S Tsukita","year":"2002","unstructured":"Tsukita S, Furuse M (2002) Claudin-based barrier in simple and stratified cellular sheets. Curr Opin Cell Biol 14:531\u2013536","journal-title":"Curr Opin Cell Biol"},{"key":"483_CR41","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.jaci.2016.10.004","volume":"138","author":"T Nomura","year":"2016","unstructured":"Nomura T, Kabashima K (2016) Advances in atopic dermatitis in 2015. J\u00a0Allergy Clin Immunol 138:1548\u20131555","journal-title":"J Allergy Clin Immunol"},{"key":"483_CR42","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1749-6632.1985.tb50420.x","volume":"455","author":"BA Dale","year":"1985","unstructured":"Dale BA, Resing KA, Lonsdale-Eccles JD (1985) Filaggrin: a\u00a0keratin filament associated protein. Ann N Y Acad Sci 455:330\u2013342","journal-title":"Ann N Y Acad Sci"},{"key":"483_CR43","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/j.ajpath.2011.01.053","volume":"178","author":"R Gruber","year":"2011","unstructured":"Gruber R et\u00a0al (2011) Filaggrin genotype in ichthyosis vulgaris predicts abnormalities in epidermal structure and function. Am J Pathol 178:2252\u20132263","journal-title":"Am J Pathol"},{"key":"483_CR44","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/jid.2011.393","volume":"132","author":"SJ Brown","year":"2012","unstructured":"Brown SJ, McLean WHI (2012) One remarkable molecule: filaggrin. J\u00a0Invest Dermatol 132:751\u2013762","journal-title":"J Invest Dermatol"},{"key":"483_CR45","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/ng1767","volume":"38","author":"CNA Palmer","year":"2006","unstructured":"Palmer CNA et al (2006) Common loss-of-function variants of the epidermal barrier protein filaggrin are a\u00a0major predisposing factor for atopic dermatitis. Nat Genet 38:441\u2013446","journal-title":"Nat Genet"},{"key":"483_CR46","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jaci.2008.02.014","volume":"121","author":"S Weidinger","year":"2008","unstructured":"Weidinger S et\u00a0al (2008) Filaggrin mutations, atopic eczema, hay fever, and asthma in children. J\u00a0Allergy Clin Immunol 121:1203\u20131209.e1","journal-title":"J Allergy Clin Immunol"},{"key":"483_CR47","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/jid.2008.413","volume":"129","author":"SJ Brown","year":"2009","unstructured":"Brown SJ, McLean WHI (2009) Eczema genetics: current state of knowledge and future goals. J\u00a0Invest Dermatol 129:543\u2013552","journal-title":"J Invest Dermatol"},{"key":"483_CR48","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1016\/j.jaci.2009.07.012","volume":"124","author":"MD Howell","year":"2009","unstructured":"Howell MD et\u00a0al (2009) Cytokine modulation of atopic dermatitis filaggrin skin expression. J\u00a0Allergy Clin Immunol 124:R7\u2013R12","journal-title":"J Allergy Clin Immunol"},{"key":"483_CR49","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1093\/hmg\/ddt317","volume":"22","author":"S Weidinger","year":"2013","unstructured":"Weidinger S et al (2013) A genome-wide association study of atopic dermatitis identifies loci with overlapping effects on asthma and psoriasis. Hum Mol Genet 22:4841\u20134856","journal-title":"Hum Mol Genet"},{"key":"483_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s13223-016-0158-5","author":"L Bin","year":"2016","unstructured":"Bin L, Leung DYM (2016) Genetic and epigenetic studies of atopic dermatitis. Allergy Asthma Clin Immunol. doi:\n                        10.1186\/s13223-016-0158-5","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"20","key":"483_CR51","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jaci.2010.05.045","volume":"126","author":"E Sonkoly","year":"2010","unstructured":"Sonkoly E et al (2010) MiR-155 is overexpressed in patients with atopic dermatitis and modulates T\u2011cell proliferative responses by targeting cytotoxic T lymphocyte-associated antigen 4. J\u00a0Allergy Clin Immunol 126(20):581\u2013589","journal-title":"J Allergy Clin Immunol"},{"key":"483_CR52","doi-asserted-by":"crossref","first-page":"e115448","DOI":"10.1371\/journal.pone.0115448","volume":"9","author":"Y Lv","year":"2014","unstructured":"Lv Y et\u00a0al (2014) Profiling of serum and urinary microRNAs in children with atopic dermatitis. PLOS ONE 9:e115448","journal-title":"PLOS ONE"},{"key":"483_CR53","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMoa013536","volume":"348","author":"G Lack","year":"2003","unstructured":"Lack G, Fox D, Northstone K, Golding J, Avon Longitudinal Study of Parents and Children Study Team (2003) Factors associated with the development of peanut allergy in childhood. N\u00a0Engl J Med 348:977\u2013985","journal-title":"N Engl J Med"},{"key":"483_CR54","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jaci.2014.10.007","volume":"135","author":"HA Brough","year":"2015","unstructured":"Brough HA et\u00a0al (2015) Atopic dermatitis increases the effect of exposure to peanut antigen in dust on peanut sensitization and likely peanut allergy. J\u00a0Allergy Clin Immunol 135:164\u2013170","journal-title":"J Allergy Clin Immunol"},{"key":"483_CR55","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jaci.2014.08.011","volume":"134","author":"HA Brough","year":"2014","unstructured":"Brough HA et al (2014) Peanut allergy: effect of environmental peanut exposure in children with filaggrin loss-of-function mutations. J\u00a0Allergy Clin Immunol 134:867\u2013875.e1","journal-title":"J Allergy Clin Immunol"},{"key":"483_CR56","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/jid.2013.19","volume":"133","author":"JI Silverberg","year":"2013","unstructured":"Silverberg JI, Hanifin J, Simpson EL (2013) Climatic factors are associated with childhood eczema prevalence in US. J\u00a0Invest Dermatol 133:1752\u20131759","journal-title":"J Invest Dermatol"},{"key":"483_CR57","doi-asserted-by":"publisher","first-page":"e0119501","DOI":"10.1371\/journal.pone.0119501","volume":"10","author":"E-H Kim","year":"2015","unstructured":"Kim E\u2011H et al (2015) Indoor air pollution aggravates symptoms of atopic dermatitis in children. PLOS ONE 10:e0119501. doi:\n                        10.1371\/journal.pone.0119501","journal-title":"PLOS ONE"},{"key":"483_CR58","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/bjd.14039","volume":"173","author":"CC Huang","year":"2015","unstructured":"Huang CC et\u00a0al (2015) Prenatal air pollutant exposure and occurrence of atopic dermatitis. Br J Dermatol 173:981\u2013988","journal-title":"Br J Dermatol"},{"key":"483_CR59","doi-asserted-by":"crossref","first-page":"639","DOI":"10.5271\/sjweh.3452","volume":"40","author":"AD Larsen","year":"2014","unstructured":"Larsen AD et al (2014) Exposure to psychosocial job strain during pregnancy and odds of asthma and atopic dermatitis among 7\u2011year old children - a\u00a0prospective cohort study. Scand J Work Environ Health 40:639\u2013648","journal-title":"Scand J Work Environ Health"},{"key":"483_CR60","doi-asserted-by":"crossref","first-page":"e113552","DOI":"10.1371\/journal.pone.0113552","volume":"9","author":"EMJ Peters","year":"2014","unstructured":"Peters EMJ et\u00a0al (2014) Mental stress in atopic dermatitis \u2013 neuronal plasticity and the cholinergic system are affected in atopic dermatitis and in response to acute experimental mental stress in a\u00a0randomized controlled pilot study. PLOS ONE 9:e113552","journal-title":"PLOS ONE"},{"key":"483_CR61","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaad.2013.10.036","volume":"70","author":"JJ Chen","year":"2014","unstructured":"Chen JJ, Applebaum DS, Sun GS, Pflugfelder SC (2014) Atopic keratoconjunctivitis: a review. J\u00a0Am Acad Dermatol 70:569\u2013575","journal-title":"J Am Acad Dermatol"},{"key":"483_CR62","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/ACI.0b013e32833e16e4","volume":"10","author":"S Guglielmetti","year":"2010","unstructured":"Guglielmetti S, Dart JK, Calder V (2010) Atopic keratoconjunctivitis and atopic dermatitis. Curr Opin Allergy Clin Immunol 10:478\u2013485","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"483_CR63","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/09273949409057069","volume":"2","author":"YA Akova","year":"1994","unstructured":"Akova YA, Rodriguez A, Foster CS (1994) Atopic keratoconjunctivitis. Ocul Immunol Inflamm 2:125\u2013144","journal-title":"Ocul Immunol Inflamm"},{"key":"483_CR64","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/3-540-31226-9_14","volume-title":"Cornea and external eye disease","author":"B Manzouri","year":"2006","unstructured":"Manzouri B, Flynn T, Ono SJ (2006) Cornea and external eye disease. Springer, Berlin, S\u00a0209\u2013224 doi:\n                        10.1007\/3-540-31226-9_14"},{"key":"483_CR65","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.iac.2010.06.004","volume":"30","author":"B Bielory","year":"2010","unstructured":"Bielory B, Bielory L (2010) Atopic dermatitis and keratoconjunctivitis. Immunol Allergy Clin North Am 30:323\u2013336","journal-title":"Immunol Allergy Clin North Am"},{"key":"483_CR66","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/IJG.0000000000000069","volume":"24","author":"K Takakuwa","year":"2015","unstructured":"Takakuwa K et\u00a0al (2015) Atopic glaucoma: clinical and Pathophysiological analysis. J\u00a0Glaucoma 24:662\u2013668","journal-title":"J Glaucoma"},{"key":"483_CR67","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0021-5155(00)00174-X","volume":"44","author":"T Hida","year":"2000","unstructured":"Hida T, Tano Y, Okinami S, Ogino N, Inoue M (2000) Multicenter retrospective study of retinal detachment associated with atopic dermatitis. Jpn J Ophthalmol 44:407\u2013418","journal-title":"Jpn J Ophthalmol"},{"key":"483_CR68","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s00347-003-0809-z","volume":"100","author":"C Kallen","year":"2003","unstructured":"Kallen C et\u00a0al (2003) Atopic keratoconjunctivitis: probably a\u00a0risk factor for the development of conjuntival carcinoma. Ophthalmologe 100:808\u2013814","journal-title":"Ophthalmologe"},{"key":"483_CR69","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00003226-200303000-00011","volume":"22","author":"C Heinz","year":"2003","unstructured":"Heinz C, Fanihagh F, Steuhl K\u2011P (2003) Squamous cell carcinoma of the conjunctiva in patients with atopic eczema. Cornea 22:135\u2013137","journal-title":"Cornea"},{"key":"483_CR70","first-page":"1182","volume":"24","author":"P Rundle","year":"2010","unstructured":"Rundle P, Mudhar HS, Rennie I (2010) Conjunctival intra-epithelial neoplasia occurring in young patients with asthma. Eye Lond Engl 24:1182\u20131185","journal-title":"Eye Lond Engl"},{"key":"483_CR71","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1067\/mai.2000.111238","volume":"106","author":"L Bielory","year":"2000","unstructured":"Bielory L (2000) Allergic and immunologic disorders of the eye. Part II: ocular allergy. J\u00a0Allergy Clin Immunol 106:1019\u20131032","journal-title":"J Allergy Clin Immunol"},{"key":"483_CR72","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0161-6420(92)31995-5","volume":"99","author":"SJ Tuft","year":"1992","unstructured":"Tuft SJ, Ramakrishnan M, Seal DV, Kemeny DM, Buckley RJ (1992) Role of staphylococcus aureus in chronic allergic conjunctivitis. Ophthalmology 99:180\u2013184","journal-title":"Ophthalmology"},{"key":"483_CR73","first-page":"49","volume":"9","author":"R Sarkar","year":"2016","unstructured":"Sarkar R et\u00a0al (2016) Periorbital hyperpigmentation: a comprehensive review. J\u00a0Clin Aesthetic Dermatol 9:49\u201355","journal-title":"J Clin Aesthetic Dermatol"},{"issue":"Suppl 1","key":"483_CR74","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000053599","volume":"120","author":"H Suto","year":"1999","unstructured":"Suto H et\u00a0al (1999) NC\/Nga mice: a\u00a0mouse model for atopic dermatitis. Int Arch Allergy Immunol 120(Suppl 1):70\u201375","journal-title":"Int Arch Allergy Immunol"},{"key":"483_CR75","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10384-003-0048-5","volume":"48","author":"N Inada","year":"2004","unstructured":"Inada N, Shoji J, Tabuchi K, Saito K, Sawa M (2004) Histological study on mast cells in conjunctiva of NC\/Nga mice. Jpn J Ophthalmol 48:189\u2013194","journal-title":"Jpn J Ophthalmol"},{"key":"483_CR76","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1055\/s-2001-18665","volume":"218","author":"K Mayer","year":"2001","unstructured":"Mayer K, Reinhard T, Reis A, B\u00f6hringer D, Sundmacher R (2001) FK 506 ointment 0.1\u202f% \u2013 a new therapeutic option for atopic blepharitis. Clinical trial with 14 patients. Klin Monatsbl Augenheilkd 218:733\u2013736","journal-title":"Klin Monatsbl Augenheilkd"},{"issue":"828","key":"483_CR77","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00347-007-1608-8","volume":"104","author":"C Auw-Haedrich","year":"2007","unstructured":"Auw-Haedrich C, Reinhard T (2007) Chronic blepharitis. Pathogenesis, clinical features, and therapy. Ophthalmologe 104(828):817\u2013826","journal-title":"Ophthalmologe"},{"key":"483_CR78","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1398-9995.2007.01414.x","volume":"62","author":"Y Hu","year":"2007","unstructured":"Hu Y et\u00a0al (2007) The differences of tear function and ocular surface findings in patients with atopic keratoconjunctivitis and vernal keratoconjunctivitis. Allergy 62:917\u2013925","journal-title":"Allergy"},{"key":"483_CR79","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.ophtha.2012.04.001","volume":"119","author":"OMA Ibrahim","year":"2012","unstructured":"Ibrahim OMA et al (2012) In vivo confocal microscopy evaluation of meibomian gland dysfunction in atopic-keratoconjunctivitis patients. Ophthalmology 119:1961\u20131968","journal-title":"Ophthalmology"},{"key":"483_CR80","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00004397-198802840-00009","volume":"28","author":"RJ Buckley","year":"1988","unstructured":"Buckley RJ (1988) Vernal keratoconjunctivitis. Int Ophthalmol Clin 28:303\u2013308","journal-title":"Int Ophthalmol Clin"},{"key":"483_CR81","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0091-6749(97)70279-3","volume":"100","author":"DP Metz","year":"1997","unstructured":"Metz DP, Hingorani M, Calder VL, Buckley RJ, Lightman SL (1997) T\u2011cell cytokines in chronic allergic eye disease. J\u00a0Allergy Clin Immunol 100:817\u2013824","journal-title":"J Allergy Clin Immunol"},{"key":"483_CR82","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/ACI.0b013e3282ef8674","volume":"7","author":"A Leonardi","year":"2007","unstructured":"Leonardi A, De Dominicis C, Motterle L (2007) Immunopathogenesis of ocular allergy: a\u00a0schematic approach to different clinical entities. Curr Opin Allergy Clin Immunol 7:429\u2013435","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"483_CR83","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1365-2222.2000.00699.x","volume":"30","author":"E Uchio","year":"2000","unstructured":"Uchio E, Ono SY, Ikezawa Z, Ohno S (2000) Tear levels of interferon-gamma, interleukin (IL) -2, IL-4 and IL-5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitis. Clin Exp Allergy 30:103\u2013109","journal-title":"Clin Exp Allergy"},{"key":"483_CR84","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1080\/02713680500196715","volume":"30","author":"M Dogru","year":"2005","unstructured":"Dogru M et\u00a0al (2005) Ocular surface and MUC5AC alterations in atopic patients with corneal shield ulcers. Curr Eye Res 30:897\u2013908","journal-title":"Curr Eye Res"},{"key":"483_CR85","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.jaci.2006.08.030","volume":"118","author":"S Ying","year":"2006","unstructured":"Ying S, Meng Q, Corrigan CJ, Lee TH (2006) Lack of filaggrin expression in the human bronchial mucosa. J\u00a0Allergy Clin Immunol 118:1386\u20131388","journal-title":"J Allergy Clin Immunol"},{"key":"483_CR86","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/sj.jid.5701208","volume":"128","author":"A Benedetto De","year":"2008","unstructured":"De Benedetto A, Qualia CM, Baroody FM, Beck LA (2008) Filaggrin expression in oral, nasal, and esophageal mucosa. J\u00a0Invest Dermatol 128:1594\u20131597","journal-title":"J Invest Dermatol"},{"key":"483_CR87","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000355965","volume":"163","author":"T Lapp","year":"2013","unstructured":"Lapp T et\u00a0al (2013) Analysis of Filaggrin Mutations and Expression in Corneal Specimens from Patients with or without Atopic Dermatitis. Int Arch Allergy Immunol 163:20\u201324","journal-title":"Int Arch Allergy Immunol"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-017-0483-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-017-0483-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-017-0483-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,13]],"date-time":"2017-06-13T11:29:17Z","timestamp":1497353357000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-017-0483-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,30]]},"references-count":87,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["483"],"URL":"https:\/\/doi.org\/10.1007\/s00347-017-0483-1","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,30]]}}}